PDMA six-month extension

FDA is further delaying enactment of certain requirements of the Prescription Drug Marketing Act final rule relating to unauthorized distribution of prescription drugs from Oct. 1 to April 1, 2002. "The delay will give distributors additional time to exhaust inventories of drugs that do not have acceptable pedigrees to avoid economic harm," the final rule published in the March 1 Federal Register states. FDA will submit recommendations on the final rule to the House Appropriations Committee by March 15; the report was originally due to Congress by Jan. 15 (1"The Pink Sheet" Nov. 6, 2000, p. 14)